Cross Shawn — SEC insider filings
SEC reporting owner CIK 1734779. 29 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2021-03-03 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 13 filings — 482,472 shares, $1,904,871 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 45.
- Largest priced transaction: sale of 15,896 shares @ $25.03 ($397,877) in Pacira BioSciences, Inc., filed 2025-12-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | 9 | — | 7 legs · 62,060 sh · $1,521,351 | 20 |
| Applied Molecular Transport Inc. (AMTI) | CEO & Chair of the Board, Director | 15 | — | 15 legs · 420,412 sh · $383,520 | 18 |
| Cyclo Therapeutics, Inc. (CYTH) | Director | 5 | — | — | 7 |
Insider filings — Cross Shawn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Pacira BioSciences, Inc. (PCRX) | Code (U): 9,210 @ $36.50 · Disposition to issuer (D): 86,591 @ $36.50 · Disposition to issuer (D): 150,000 (derivative) | EDGAR |
| 2026-11-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 9,540 @ $36.39 | EDGAR |
| 2026-04-24 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 12,941 @ $16.45 · Sale (S): 12,941 @ $25.16 · Option exercise (M): 12,941 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 7,714 @ $16.45 · Sale (S): 7,714 @ $25.14 · Option exercise (M): 2,845 @ $16.45 · Sale (S): 2,845 @ $25.01 · Option exercise (M): 1,500 @ $16.45 · Sale (S): 1,500 @ $25.01 · +3 more | EDGAR |
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 49,091 @ $0 | EDGAR |
| 2025-12-11 | 4 | Pacira BioSciences, Inc. (PCRX) | Option exercise (M): 15,896 @ $16.45 · Sale (S): 15,896 @ $25.03 · Option exercise (M): 9,104 @ $16.45 · Sale (S): 9,104 @ $25.14 · Option exercise (M): 15,896 (derivative) @ $0 · Option exercise (M): 9,104 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Sale (S): 12,060 @ $22.09 | EDGAR |
| 2025-11-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 6,690 @ $21.38 | EDGAR |
| 2025-03-03 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 28,597 @ $0 | EDGAR |
| 2024-11-18 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 17,228 @ $0 | EDGAR |
| 2024-11-05 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 9,028 @ $0 | EDGAR |
| 2024-06-05 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 8,887 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Applied Molecular Transport Inc. (AMTI) | Disposition to issuer (D): 545,499 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Disposition to issuer (D): 63,000 (derivative) @ $0 · Disposition to issuer (D): 94,500 (derivative) @ $0 · Disposition to issuer (D): 84,000 (derivative) @ $0 · Disposition to issuer (D): 668,000 (derivative) @ $0 | EDGAR |
| 2023-12-28 | 4 | Cyclo Therapeutics, Inc. (CYTH) | Grant/award (A): 72,606 @ $0 · Grant/award (A): 88,910 (derivative) @ $0 | EDGAR |
| 2023-11-24 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 110,802 @ $0.16 | EDGAR |
| 2023-11-16 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 90,447 @ $0.16 | EDGAR |
| 2023-10-04 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 3,293 @ $0.24 · Sale (S): 536 @ $0.24 · Sale (S): 477 @ $0.24 · Sale (S): 1,253 @ $0.21 | EDGAR |
| 2023-10-02 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 886,111 @ $0 · Sale (S): 193,960 @ $0.16 | EDGAR |
| 2023-03-27 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 668,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 934 @ $0.50 | EDGAR |
| 2022-12-06 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 3,893 @ $1.05 | EDGAR |
| 2022-09-06 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 468 @ $1.42 · Sale (S): 416 @ $1.42 | EDGAR |
| 2022-06-03 | 4 | Applied Molecular Transport Inc. (AMTI) | Sale (S): 1,767 @ $2.97 · Sale (S): 2,166 @ $3.04 | EDGAR |
| 2022-05-18 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 18,000 @ $0 · Grant/award (A): 84,000 (derivative) @ $0 | EDGAR |
| 2022-02-16 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 20,250 @ $0 · Grant/award (A): 94,500 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 31,500 @ $0 | EDGAR |
| 2021-08-23 | 4 | Applied Molecular Transport Inc. (AMTI) | Option exercise (M): 300 @ $4.61 · Sale (S): 300 @ $30.01 · Option exercise (M): 9,700 @ $4.61 · Sale (S): 9,700 @ $30.12 · Option exercise (M): 300 (derivative) @ $0 · Option exercise (M): 9,700 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Applied Molecular Transport Inc. (AMTI) | Grant/award (A): 63,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1734779 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs